PPARγ agonist (experimental)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PPARγ agonist (experimental), covering 2020-10-19 to 2020-10-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer [Phase 1]